Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,235	1,861	604	1,444	1,370	1,442
Market Cap Growth	340.84%	207.99%	-58.17%	5.42%	-4.98%	-64.31%
Enterprise Value	4,929	4,512	3,414	4,063	3,968	4,055
PE Ratio	-	-22.15	-4.65	135.93	15.04	-3.98
PS Ratio	0.90	0.78	0.27	0.69	0.69	0.89
PB Ratio	-29.20	94.07	2.02	4.01	4.52	6.21
P/FCF Ratio	14.33	6.23	37.05	7.57	4.32	-31.70
P/OCF Ratio	11.09	5.38	9.28	5.97	3.61	845.55
EV/Sales Ratio	1.98	1.89	1.54	1.94	1.99	2.49
EV/EBITDA Ratio	16.48	12.38	12.40	10.38	10.78	10.22
EV/EBIT Ratio	68.21	33.40	97.40	25.69	29.90	21.38
EV/FCF Ratio	31.60	15.10	209.39	21.29	12.51	-89.17
Debt / Equity Ratio	-43.09	139.05	9.53	7.98	9.71	11.92
Debt / EBITDA Ratio	9.18	7.55	10.34	7.35	8.00	6.97
Debt / FCF Ratio	17.60	9.21	174.49	15.07	9.29	-60.82
Quick Ratio	0.87	0.84	1.03	1.36	1.46	1.38
Current Ratio	1.65	1.63	1.88	2.25	2.29	2.20
Asset Turnover	0.70	0.66	0.57	0.53	0.48	0.41
Interest Coverage	0.32	0.64	0.22	1.16	0.91	1.13
Return on Equity (ROE)	-111.50%	-34.90%	-41.00%	3.10%	29.60%	-104.80%
Return on Assets (ROA)	-4.70%	-2.30%	-3.30%	0.30%	2.20%	-9.00%
Return on Capital (ROIC)	5.31%	6.85%	-3.00%	2.30%	2.81%	140.19%
Earnings Yield	-7.55%	-4.51%	-21.52%	0.74%	6.65%	-25.10%
FCF Yield	6.98%	16.06%	2.70%	13.22%	23.15%	-3.15%
Buyback Yield / Dilution	-102.01%	-16.69%	0.58%	-1.95%	-12.72%	-3.81%
Total Shareholder Return	-102.01%	-16.69%	0.58%	-1.95%	-12.72%	-3.81%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).